Author

E. M. Posadas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Di Vizio· 2 shared A. E. Giuliano· 1 shared B. Gallent· 1 shared B. S. Knudsen· 1 shared B. Zhang· 1 shared C. Morrissey· 1 shared C. Qian· 1 shared E. A. Mostaghel· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Di Vizio

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNA

M. M. Murata, F. Igari, R. Urbanowicz, L. Mouakkad, S. Kim, Z. Chen, D. Di Vizio, E. M. Posadas, A. E. Giuliano, H. Tanaka

The paper introduces GAPF-seq, a method to detect structural variants in cfDNA, achieving high accuracy in distinguishing tumors from controls.

bioRxiv · Oct 25, 2023 · PreprintCancer Biology

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

C. Qian, Q. Yang, M. Rotinen, R. Huang, h. Kim, B. Gallent, Y. Yan, R. M. Cadaneanu, B. Zhang, S. Kaochar, S. J. Freedland, E. M. Posadas, L. Ellis, D. Di Vizio, C. Morrissey, , M. R. Freeman

This study identifies ONECUT2 as a master transcription factor that drives resistance in prostate cancer through multiple mechanisms, including activation of neuroendocrine and adenocarcinoma variants, and shows that its inhibition can suppress treatment-resistant lineage plasticity.

bioRxiv · Sep 28, 2023 · PreprintCancer Biology